Ensysce Biosciences Inc (ENSC)

08:38 AM

Ensysce Faces New Nasdaq Issue as Deadline Nears - Bez Kabli

08:38 AM

May 23, 2026

Ensysce Biosciences, Inc. Files Form 8-K: Company Details, Nasdaq Listing, and Compliance Update - Minichart

May 23, 2026

May 22, 2026

Ensysce Biosciences receives Nasdaq notice for non-compliance with equity rule - Investing.com

May 22, 2026

May 22, 2026

Ensysce Biosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

May 22, 2026

May 22, 2026

Ensysce Biosciences (NASDAQ: ENSC) warned on Nasdaq equity listing rule - Stock Titan

May 22, 2026

May 18, 2026

Ensysce Biosciences : Corporate Overview - marketscreener.com

May 18, 2026

May 18, 2026

ENSC Advancing Testing and Expanding Potential - Yahoo Finance

May 18, 2026

May 18, 2026

Ensysce Biosciences (ENSC) Rallies +0.54% as Bulls Target $0.29 2026-05-18OBV Divergence - Newser

May 18, 2026

May 17, 2026

Press Releases about Ensysce Biosciences, Inc.Common Stock - The Chronicle-Journal

May 17, 2026

May 17, 2026

Ensysce Biosciences, Inc.Common Stock (Nasdaq:ENSC) Stock Quote - The Chronicle-Journal

May 17, 2026

May 16, 2026

Ensysce Biosciences (ENSC) price target decreased by 34.79% to 16.78 - MSN

May 16, 2026

May 15, 2026

Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2026

May 15, 2026

Ensysce biosciences launches formal review of strategic alternativesSEC filing - marketscreener.com

May 15, 2026

May 15, 2026

Ensysce Biosciences Launches Formal Review Of Strategic AlternativesSEC Filing - TradingView

May 15, 2026

May 15, 2026

Ensysce Biosciences : Earnings Release Q1 2026 - marketscreener.com

May 15, 2026

May 15, 2026

ENSC: Clinical milestones and new financing highlight Q1 2026 amid ongoing R&D-driven losses - TradingView

May 15, 2026

May 15, 2026

Wider Q1 loss leaves Ensysce (NASDAQ: ENSC) with limited cash runway - Stock Titan

May 15, 2026

May 15, 2026

Ensysce Biosciences (ENSC) posts Q1 2026 loss, cash squeeze and strategic review - Stock Titan

May 15, 2026

May 15, 2026

This biotech is testing an opioid designed to limit overdose risk - Stock Titan

May 15, 2026

May 15, 2026

ENSC Q1'26 Earnings: EPS estimate is (0.73) USD - TradingView

May 15, 2026

May 13, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

May 13, 2026

May 13, 2026

Nasdaq most active stocks: - MSN

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 12, 2026

Ensysce receives Taiwan patent for overdose protection technology - Investing.com UK

May 12, 2026

May 12, 2026

Ensysce receives Taiwan patent for overdose protection technology By Investing.com - Investing.com South Africa

May 12, 2026

May 12, 2026

Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology - Corsicana Daily Sun

May 12, 2026

May 12, 2026

Opioid overdose-protection tech MPAR gets Taiwan patent to 2042 - Stock Titan

May 12, 2026

May 11, 2026

Sold 🍀🤞🏻 - Moomoo

May 11, 2026

May 11, 2026

$Ensysce Biosciences (ENSC.US)$ something in the milk aint clean…LG - Moomoo

May 11, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 08, 2026

Ensysce Biosciences Inc expected to post a loss of 73 cents a shareEarnings Preview - TradingView

May 08, 2026

May 08, 2026

Why are smart money investors paying attention to Ensysce Biosciences (ENSC)? (Tumbles Hard) 2026-05-08Wall Street Picks - Newser

May 08, 2026

May 08, 2026

Ensysce CEO outlines abuse-resistant opioid approach in Amsterdam - Stock Titan

May 08, 2026

May 08, 2026

Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam - Corsicana Daily Sun

May 08, 2026

May 08, 2026

What Ensysce Biosciences (ENSC) disclosed about cash conversion | Q4 2025: Earnings Beat EstimatesFree Stock Community - Newser

May 08, 2026

May 03, 2026

ENSC Ensysce Biosciences reports narrower Q4 2025 loss than estimates, shares climb after earnings release.Senior Analyst Forecasts - newser.com

May 03, 2026

May 01, 2026

ENSC Should I Buy - Intellectia AI

May 01, 2026

Apr 28, 2026

ENSC - Finviz

Apr 28, 2026

Apr 28, 2026

ENSC News | ENSYSCE BIOSCIENCES INC (NASDAQ:ENSC) - ChartMill

Apr 28, 2026

Apr 22, 2026

Ensysce Biosciences (ENSC) Sector Trends | Q4 2025: EPS Beats ForecastsCommunity Chart Signals - UBND thành phố Hải Phòng

Apr 22, 2026

Apr 16, 2026

Ensysce receives IRB approval for final opioid overdose study phase By Investing.com - Investing.com India

Apr 16, 2026

Apr 16, 2026

Ensysce Biosciences Secures IRB Approval for Final Phase of Clinical Study - National Today

Apr 16, 2026

Apr 16, 2026

Ensysce receives IRB approval for final opioid overdose study phase - Investing.com

Apr 16, 2026

Apr 16, 2026

Opioid with built-in overdose safeguard enters final study stage - Stock Titan

Apr 16, 2026

Apr 16, 2026

[EFFECT] Ensysce Biosciences, Inc. SEC Filing - Stock Titan

Apr 16, 2026

Apr 13, 2026

Price Action: Will Ensysce Biosciences Inc benefit from geopolitical trendsTrade Volume Summary & Weekly High Potential Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Bull Run: Is Ensysce Biosciences Inc subject to activist investor interest2026 Dividend Review & Free Reliable Trade Execution Plans - baoquankhu1.vn

Apr 13, 2026